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Abstract Infectious agents are likely to play a role in
the pathogenesis of chronic inflammatory diseases,
including abdominal aortic aneurysms (AAAs). The goal
of this study was to determine if Borrelia burgdorferi
sensu lato (sl), a microorganism responsible for Lyme
disease, is involved in the etiology of AAAs. The
presence of serum antibodies against B. burgdorferi sl
was measured with enzyme-linked immunosorbent assay
( E L I S A )a n dc o n f i r m e db yW e s t e r nb l o t t i n gi n9 6A A A
and 108 peripheral artery disease (PAD) patients. Poly-
merase chain reaction (PCR) was used for the detection of
Borrelia-specific DNA in the aneurysm wall. Among
AAA patients 34% and among PAD patients 16% were
seropositive for B. burgdorferi sl antibodies (Fisher’s
exact test, p=0.003; odds ratio [OR] 2.79; 95% confi-
dence interval [CI] 1.37–5.85). In the German general
population, 3–17% are seropositive for Borrelia anti-
bodies. No Borrelia DNA was detected in the aneurysm
wall. Our findings suggest a relationship between AAAs
and B. burgdorferi sl. We hypothesize that the underlying
mechanism for B. burgdorferi sl in AAA formation is
s i m i l a rt ot h a tb yt h es p i r o c h e t eTreponema pallidum;
alternatively, AAAs could develop due to induced auto-
immunity via molecular mimicry due to similarities
between some of the B. burgdorferi sl proteins and aortic
proteins.
Introduction
Abdominal aortic aneurysm (AAA), defined as a dilatation
greater than 3 cm of the infrarenal abdominal aorta, is a
complex disease of the aging population [1]. Rupture of
AAAs is associated with a high mortality rate, making
aortic aneurysms the 15th leading cause of death among
Caucasians over the age of 65 years in the USA [2]. The
pathogenesis of AAAs is complex and poorly understood.
Characteristics of AAA pathogenesis includeinflammation,
vascular smooth muscle cell (VSMC) apoptosis, extracellular
matrix degradation, and oxidative stress [3]. T-cells in AAA
patients secrete proinflammatory cytokines [4], and natural
killer cells display increased cytotoxicity [5]. Autoimmunity
may also play a role in AAA development and progression
[6, 7]. Several studies have examined microorganisms,
including Chlamydia [8–10], Mycoplasma pneumoniae [9],
Helicobacter pylori [10], human cytomegalovirus (HCMV)
[11], herpes simplex virus (HSV) [12], and different oral
bacteria [13–15], as possible triggers for the development of
AAAs, but the data are inconclusive. A nowadays rarely seen
cause, but a clinically and histologically proven etiological
factor, is Treponema pallidum; the infection leads to luetic
thoracic aortic aneurysm in the late stage of syphilitic disease
[16]. T. pallidum is a member of the spirochete family
(Treponemataceae); other members of the spirochete family
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causative organism of relapsing fever, numerous Borrelia
species are colonizing in humans and animals. The spirochete
B. burgdorferi is known to cause human Lyme disease in
Europe. To date, seven pathogenic B. burgdorferi species in
humans have been described, and are collectively referred to
as B. burgdorferi sensu lato (sl): B. burgdorferi sensu stricto
(ss), B. afzelii, B. garinii, B. spielmanii, B. valaisiana, B.
lusitaniae,a n dB. bissettii [17].
There have been few case reports on intracranial [18, 19]
and coronary artery [20] aneurysms in patients infected
with B. burgdorferi sl.
The aim of this study was to investigate the presence of
antibodies against B. burgdorferi sl in patients with AAAs
compared to patients with peripheral artery disease (PAD)
in order to test the hypothesis that B. burgdorferi sl is an
etiological agent in AAA development.
Materials and methods
Patients
In this case–control study, 96 consecutive patients diag-
nosed with AAA using ultrasonography or computed
tomography (diameter >30 mm) were recruited at the
Vascular Surgery Department, Technical University of
Dresden, Germany (Table 1). The mean age of the patients
was 71.3±9.1 years and 89 (93%) were males. Most (80;
83%) patients had a diameter of the AAA ≥5 cm and
underwent elective repair (open or endovascular) and 14
(15%) patients had a ruptured AAA.
The control group comprised of 108 patients with PAD,
with mean age of 69.1±9.6 years, and 94 (87%) males. The
PADpatientswereapproximatelyage-andsex-matchedtothe
AAA cases. AAA was excluded by ultrasonography. The
severityofPADwasassessedusingtheFontaineclassification
for chronic ischemia. Altogether, 49 (45%) patients had PAD
Fontaine stage IIb, 23 (21%) Fontaine stage III, and 36 (33%)
had Fontaine stage IV. They all underwent endovascular or
open surgery for revascularization (Table 1).
The study was approved by the Ethics Committee of the
Medical Faculty at the Technical University Dresden,
Germany (EK 316122008). All patients gave informed
written consent prior to enrolment into the study.
Sample collection
Venous blood samples were collected with Serum Monov-
ette® (Sarstedt AG & Co., Nümbrecht, Germany). Samples
were centrifuged immediately and stored at −80°C.
AAA wall specimens were obtained during surgery
from 26 patients with aortic diameter >5 cm; of those,
ten were known to be seronegative and 16 seropositive
for Borrelia antibodies. In each group, four patients had
ruptured AAAs. AAA wall tissue specimens were snap-
frozen in liquid nitrogen immediately after harvesting and
stored at −80°C.
Immunological tests
Antibodies against B. burgdorferi sl were analyzed accord-
ing to the Quality Standards for the Microbiological
Diagnosis of Infectious Disease (MiQ) [21] 12/2000 and
DIN58969-44 by enzyme-linked immunosorbent assay
(ELISA), and positive results were confirmed by Western
blots. Borrelia afzelii+VlsE IgG ELISA (Pko strain) and
Borrelia afzelii IgM ELISA test kits (Genzyme Virotec
GmbH, Rüsselsheim, Germany) were used as screening
tests in the serum of 96 AAA patients and 108 PAD patients
to quantify specific IgG and IgM classes.
Quantitative results were given as arbitrary ELISA units
according to the manufacturer’s instructions (positive >11 U/
ml, borderline 9–11 U/ml). According to the two-stage
diagnosis scheme MiQ [21], immunoblotting with Borrelia
LINE test kits (Genzyme Virotec GmbH, Rüsselsheim,
Germany) was carried out with samples showing borderline
and positive results in ELISA. The immunoblotting kits use
recombinant antigens against the four most common B.
burgdorferisl species (B. burgdorferi ss, B. afzelii, B. garinii,
and B. spielmanii). Other species causing Lyme disease are
not detected with the assay, but they are rare and, to date,
described only in certain geographic regions [17]. Samples
that gave positive results in both ELISA and Western blot
were considered to be positive for B. burgdorferi sl
antibodies.
Treponema pallidum hemagglutination assay (TPHA;
Immunogenetics, Heiden, Germany) was performed in
order to exclude infection with T. pallidum.
DNA analysis
DNA was extracted from AAA tissue specimens with a
method using the TRIzol reagent (Invitrogen GmbH,
Darmstadt, Germany). The nested polymerase chain reac-
tion (PCR) method approved for clinical use for the
detection of Borrelia-specific DNA and β-actin DNA as a
“housekeeping” gene was used. Nested PCR was carried
out first with eubacterial primers TPU1 and RT1 [22]
(Eurofins MWG Operon, Ebersberg, Germany) for the
screening of any bacterial DNA. In a second step,
amplification with Borrelia-specific primer BB16SF and
RT1 primer [22] (Eurofins MWG Operon, Ebersberg,
Germany) was performed according to the manufacturer’s
instructions. Positive as well as no-template controls were
included in each PCR run.
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Clinical data were evaluated by Fisher’s exact test or the
Wilcoxon rank-sum test and multivariate logistic regression
analysis. The data are expressed as mean±SD for contin-
uous variables. Fisher’s exact test was used for comparison
of the seroprevalences. Odds ratios (ORs) and 95%
confidence intervals (CIs) were also calculated. Statistical
analyses were performed using SPSS for Windows version
11.0 (SPSS, Birmingham, UK), except for the CIs for
binomial probabilities, which were calculated in R [23]. All
reported p-values are two-sided and a p-value of <0.05 was
considered to be statistically significant.
Results
The clinical data and results from the multivariate logistic
regression analysis between the study groups are presented
in Table 1. The AAA group of patients differed from the
PAD group in preoperative creatinine levels and thrombo-
cyte counts. A slight difference in the number of individuals
with a diagnosis of dyslipidemia [24] or diabetes mellitus
[25] was observed, consistent with previous studies. Also,
significantly more PAD patients were treated with clopi-
dogrel and AAA patients were treated more often with beta-
blockers. The groups were slightly different in regards to
the mean age (72 vs. 69 years), but both mean ages were
beyond the second peak of infection rate with B. burgdor-
feri sl (60 to 64 years) [26].
AAA cases and PAD controls were tested for the
presence of IgG and IgM antibodies against Borrelia with
two immunological techniques using validated reagents
approved for the clinical testing of Lyme disease in
Germany. The IgG antibodies detected by ELISA were
present in 44 (46%) AAA patients, but in only 34 (32%)
controls. The presence of IgG antibodies against B.
burgdorferi sl was confirmed in 33 (34%) AAA patients
and in 17 (16%) controls (p=0.003, Fisher’s exact test; OR
2.79; 95% CI 1.37–5.85) using immunoblotting (Fig. 1).
The lower number of positive samples observed in the
immunoblotting compared to the ELISA is expected, as
some of the samples gave only borderline positive results in
ELISA. These results illustrate the need for two-step
Table 1 Characteristics of the
study groups
Comparisons between cases and
controls were carried out using
multivariate logistic regression.
The number of individuals in
each study group for whom the
information was available is
indicated. Laboratory parame-
ters are shown as mean ± stan-
dard deviation (SD) and were
measured preoperatively
aBlood pressure ≥ 140/90 mmHg
bIncreased LDL (male and fe-
male: ≥ 4.12 mmol/l; age > 35
years) and decreased HDL
(male: ≤ 0.90 mmol/l;female ≤
1.3 mmol/l; age > 35 years)
AAA (n=96) PAD (n=108) p-value
Age, mean±SD (years) 72.3 ± 9.1 69.1 ± 9.6 0.013
Men (%) 89/96 (93) 94/108 (87) 0.249
PAD (%) 15/78 (41) 108/108 (100) <2.2×10
−16
Coronary artery disease (%) 30/78 (39) 44/107 (41) 0.762
Hypertension
a (%) 67/77 (87) 97/107 (91) 0.477
Diabetes mellitus (%) 21/77 (27) 46/107 (43) 0.031
Dyslipidemia
b (%) 50/77 (65) 87/107 (81) 0.016
Aspirin (%) 61/74 (82) 80/106 (76) 0.278
Clopidogrel (%) 3/74 (4.1) 36/106 (34) 6.9×10
−7
Calcium antagonists (%) 24/74 (32) 36/106 (34) 0.873
ACE inhibitors (%) 45/74 (61) 56/106 (53) 0.360
Diuretics (%) 38/74 (51) 54/106 (51) 1.000
Beta-blockers (%) 56/74 (76) 60/106 (57) 0.011
Statins (%) 48/74 (65) 84/106 (79) 0.040
Corticosteroids (%) 3/74 (4.1) 1/106 (0.9) 0.307
Hemoglobin (mmol/l) 8.2 ± 1.2 8.1 ± 1.2 0.379
Hematocrit 0.39 ± 0.1 0.39 ± 0.1 0.590
White blood cell count (×10
9/l) 8.6 ± 3.9 8.1 ± 2.4 0.935
Thrombocyte count (×10
9/l) 211.9 ± 67.2 257.6 ± 98.1 0.00005
HbA1c (%) 6.6 ± 1.3 6.3 ± 0.8 0.553
C-reactive protein (mg/l) 21.5 ± 41.2 17.4 ± 32.8 0.300
Cholesterol (mmol/l) 4.7 ± 1.3 4.7 ± 1.4 0.363
LDL (mmol/l) 2.9 ± 1.0 2.6 ± 1.1 0.037
HDL (mmol/l) 1.2 ± 0.4 1.2 ± 0.4 0.998
Triglycerides (mmol/l) 1.9 ± 2.0 13.7 ± 56.7 0.143
Creatinine (mmol/l) 113.5 ± 41.9 103.6 ± 99.3 2.9×10
−5
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avoid false-positives.
A summary of the Western blot results is provided in
Table 2. Serum samples from the 33 AAA patients with
positive results in the immunoblots reacted against B. afzelii
(DbpA, decorin-binding protein A) in 20 cases and against
B. garinii (p58, oligopeptide permease protein A-2) in eight
cases; the serum from six AAA cases reacted against both
species. In eight cases, only bands indicative of reaction
against B. burgdorferi sl were seen (VlsE, variable major
protein-like sequence E; OspC, outer surface protein C;
BmpA, borrelial membrane protein A). Three patients had
evidence for late-stage borreliosis by being positive for
antigens against in vitro-expressed proteins BB0323,
BBA36, and/or Crasp3 (complement regulator-acquiring
surface protein 3).
The immunoblotting bands in the 17 PAD controls were
similarly distributed. Thirteen PAD cases had bands for
DbpA and eight for p58, five of whom had both bands.
Crasp3 was not detected in any serum sample. In one case
only were antibodies for OspC detected. None of the PAD
cases had serological evidence for late-stage borreliosis
(Table 2).
None of the samples were positive for B. burgdorferi sl
IgM antibodies or showed positive TPHA test results,
ruling out syphilitic aneurysms.
DNA analysis using nested PCR on ten seropositive and
16 seronegative aortic wall specimens did not detect any B.
burgdorferi sl DNA. The failure to detect B. burgdorferi sl
DNA was unlikely to be due to technical problems, but a
true negative finding, since PCRs in which the samples
were spiked with B. burgdorferi DNA, yielded a product.
The results are consistent with a previous study [8].
Discussion
The underlying pathobiology of AAAs remains unknown,
but several characteristic features have been recognized in
the aortic wall, including chronic inflammation [7]. T-cell
invasion in the adventitia and media with the secretion of
cytokines [4, 27] and the detection of other inflammatory
cells such as neutrophils, mast cells [28], natural killer cells
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[59–64]. Only studies with both
enzyme-linked immunosorbent as-
say (ELISA) and immunoblotting
data wereincluded. The confidence
intervals for binomial probabilities
were calculated in R [23]
Table 2 Summary of immunoblotting results for abdominal aortic
aneurysm (AAA) and peripheral artery disease (PAD) patients
Borrelia classification Immunoblot
a result Number (%)
b of positive
samples in:
AAA, n=33 PAD, n=17
B. burgdorferi sl VlsE 30 (91) 17 (100)
OspC 5 (15) 1 (6)
BmpA 5 (15) 2 (12)
p83
c 6 (18) 5 (29)
BBO323
c 2 (6) –
BBA36
c 1 (3) –
Crasp3
c 3 (9) –
B. afzelii DbpA-PKo 20 (61) 13 (76)
B. garinii p58 8 (24) 8 (47)
aDescription of the bands seen in immunoblots: VlsE “vmp (variable
major protein)-like-sequence E”, in vivo experiment B. burgdorferi
lipoprotein with conserved highly immunogenic epitopes, which is a
species-independent main marker in Borrelia diagnostics; OspC “outer
surface protein C”, a highly variable surface protein of the B.
burgdorferi sl group, early IgM marker of the B-cell immune
response; BmpA “borrelial membrane protein A”, main marker of
IgG serology for disseminated Lyme borreliosis; p83 highly conserved
antigen in the B. burgdorferi sl group, an IgG marker of late-stage
borreliosis; BB0323 a hypothetical protein identified in strain B31 of
B. burgdorferi sl by genome analysis and verified by epitopes in vivo,
marker of late-stage borreliosis, frequently positive in neuroborrelio-
sis; BBA36 a lipoprotein of unknown function of B. burgdorferi sl
strain B31, verified by epitopes in vivo, marker of late-stage
borreliosis; Crasp3 “complement regulator-acquiring surface protein
3”, marker of late-stage borreliosis; DbpA-PKo “decorin-binding
protein A”, highly specific marker for B. afzelii; p58 “oligopeptide
permease protein A-2”, marker for B. garinii
bThe percentages indicate the proportion of samples positive for the
given marker among all positive samples
cMarkers for late-stage borreliosis
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infectious agents trigger the inflammatory process in
AAAs. Infectious agents as inducers of AAA development
have been studied for more than 25 years. Bacterial cultures
of thrombus and AAA wall specimens taken during open
repair operations were positive in 8–43% of cases and
revealed a variety of different microorganisms [30–32]. A
significantly higher incidence of bacterial species was
found in ruptured AAAs [33].
Using PCR-based techniques, bacterial DNA is found in
more than 80% of AAAwall specimens [13, 15]. Of interest
is that a high number of oral bacteria, associated with
bacteremia, have been detected in patients with AAAs and
other cardiovascular diseases [13, 34]. Infection with
Porphyromonas gingivalis was recently shown to be
associated with AAAs in Japanese [14] but not in
Norwegian patients [35]. In vitro experiments demonstrated
that VSMC proliferation was influenced by infection with P.
gingivalis, providing a possible mechanism for the weak-
ening of the AAA wall [36]. It is not clear, however,
whether the bacteria contribute to weakening of the aortic
wall by eliciting inflammation or whether they are
secondary colonizers of thrombus and AAAs.
Among measured serum antigens in AAA patients, the
most studied agent is C. pneumoniae [8, 10, 37, 38], which
may be involved in the initiation or progression of AAAs
[39, 40]. C. pneumoniae reactive T-lymphocytes were found
in the mononuclear cell infiltrates of AAAs [41], but
studies on detecting C. pneumonia DNA in the AAA wall
were inconsistent (Table 3)[ 8, 10]. One of these studies
screened also for Borrelia DNA in the AAA wall, with
negative results [8].
Todate,theonlyprovenbacteriumcausingaorticaneurysm
remains the spirochete T. pallidum in the manifestation of
tertiary (cardiovascular) syphilis [42]. The aneurysms occur
mostly in the ascending aorta and only in less than 5% of
cases in the abdominal aorta [43]. Diagnosis is confirmed by
serological markers or by detecting Treponema DNA using
PCR [42]. Histological examination demonstrated the inva-
sion of T. pallidum in the infected aortic wall, as well as the
presence of lymphocytes and plasma cells around the vasa
vasorum in the adventitia [42].
Nowadays, infections with T. pallidum are, however, rare
in developed countries. Infections by spirochetes in Europe
are mostly due to B. burgdorferi sl, which can cause Lyme
disease in humans; the microorganisms are transmitted by
tick bites (Ixodes ricinus in Europe) and these ticks are
vectors of more than 100 reservoir animals [44]. Risk
groups include children between the ages of 5 and 9 years
and adults of ages 60 to 64 years [26].
Apart from the infection path, Lyme disease is similar to
syphilis in passing through different stages with silent
phases of several years between the stages and affecting
skin, joints, heart, and the central nervous system [45].
Lyme disease can manifest after 1 to 10 years in a latent
stage of borreliosis. It is a chronic disease with multiple
symptoms, of which neuroborreliosis is the most common
form in Europe [45]. The acute phase of the disease can be
s k i p p e da n ds y m p t o m sc a nv a r yw i d e l y .I th a sb e e n
estimated that 3–4% of the German population have
antibodies against B. burgdorferi sl and are asymptomatic
(Fig. 1). In endemic regions, up to 17% of the population is
seropositive for B. burgdorferi sl IgG antibodies (Fig. 1).
The epidemiological significance of seroprevalence is
unknown.
Besides the known late neurological symptoms, late
vascular manifestations are also possible, as suggested by
multiple lines of evidence. First, in neuroborreliosis,
perivascular and vascular lymphocytic inflammation is
associated with the presence of B. burgdorferi sl DNA
[46]. Second, 30 days after the intradermal inoculation of B.
burgdorferi sl in mice, leukocyte infiltrates, including
plasma cells, occurred primarily in the periaortic adventitia
[47]. Third, another animal model in monkeys showed that
inoculation with B. burgdorferi sl resulted in carditis and
aortitis, with the infiltration of T-cells, plasma cells, and
macrophages; spirochetes were found in the aortic connec-
tive tissue [48]. Activation of the complement cascade as an
immune reaction against the bacterium with deposition of
the membrane attack complex was also shown [48]. Fourth,
in vitro, B. burgdorferi sl lipoprotein was shown to
upregulate transendothelial neutrophil migration [49]. Neu-
trophil recruitment in the AAAwall is thought to be critical
in AAA development based on studies in a mouse model
[50]. Fifth, carditis is found in up to 25% of Lyme disease
patients [51].
The fact that we could not detect Borrelia DNA in the
AAA wall, even with sensitive PCR-based methods, makes
us hypothesize that AAAs are not triggered by the direct
infection of the aortic wall by Borrelia.I n s t e a d ,a n
alternative disease mechanism could involve molecular
mimicry in which similar epitopes are present in the surface
of Borrelia and components of the aortic wall. In this
disease model, serologically detectable infection with
Borrelia leads, in the long run, to destruction of the aortic
tissue through autoimmune reaction. Although concrete
evidence for this hypothesis in the case of Borrelia is still
lacking, it has been suggested as the mechanism in other
studies. These studies identified a candidate autoantigen
called aortic aneurysm-associated protein-40 (AAAP-40) in
the aortic wall. Interestingly, AAAP-40 has sequence
homology with T. pallidum, HSV, and HCMV [6].
Of particular interest is the activation of complement
cascade by B. burgdorferi sl [48]. In vitro, in spite of
activation of the alternative and classical pathway in normal
human serum, B. burgdorferi sl was resistant to the
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bind to complement factor H (CFH) [53], a natural inhibitor
in the alternative pathway of the complement cascade. A
role for complement cascade in human AAA was shown
recently in a microarray-based expression analysis, where
CFH was found to be downregulated [54]. The combination
of decreased CFH expression in AAA tissue and additional
inhibition of CFH by B. burgdorferi sl may lead to over-
activation of the complement cascade, which can cause
tissue damage in the aortic wall.
Another hypothesis is that positive Borrelia serology is
only epiphenomena of the tick bites and that other
pathological ingredients in tick saliva contribute to aneurysm
development. In vitro experiments, using human microvas-
cular endothelial cells, demonstrated that tick saliva is a
negative modulator of angiogenesis-dependent wound heal-
ing and tissue repair [55]. It can induce the apoptosis of
endothelial cells by degrading ITGA5β1. ITGA5, a major
fibronectin receptor which is essential for cell growth and
development, was shown to be significantly decreased in
AAA tissue [56, 57].
One of the limitations of the current study is that no data
were available on tick bites and that Lyme disease symptoms
aretreatedmedicallyinpatientswithprevioushistoryofLyme
disease.Additionally,wedidnotanalyzedifferencesinleisure
activities, such as gardening, hiking, or hunting, which could
expose the individuals to tick bites, or take into account the
place of living (near forest areas or in more urban settings)
between the study groups. We have no reason to assume that
PAD patients were less active at the time, many years ago,
when they were exposed to B. burgdorferi sl. It is interesting
to note that the seroprevalence was higher in AAA patients
than in groups such as forestry workers considered to be at
high risk for Lyme disease (Fig. 1).
Another limitation of the study was the relatively small
number of AAA (n=96) and PAD (n=108) patients studied.
These results should, therefore, be considered as prelimi-
nary until they are confirmed in larger studies. Also, we
studied only patients from a small geographic area; thus, it
will be important to investigate other populations in the
future. Finally, the results might have been different if we
compared the AAA patients to so-called “supercontrols”
without any evidence of cardiovascular diseases, rather than
the PAD patients studied here. Our rationale for choosing
PAD patients as the control group was to minimize false-
positive findings, since both of these conditions have an
underlying inflammatory component (as shown by the
elevated C-reactive protein levels), but multiple lines of
evidence strongly suggest that, although AAA and occlu-
sive diseases share some common risk factors, they have
different pathophysiology [58].
Inconclusion,inthiscase–controlstudy,significantlymore
patientswithAAAshadB. burgdorferi sl IgG antibodies than
an age- and sex-matched control group of patients with PAD
Table 3 Summary of studies investigating the presence of serum antibodies against microorganisms in AAA patients
Microorganism Study design Sample number IgG serum Ab (%)
a,
cases/controls
DNA in the AAA wall
(%)
b, cases/controls
Study
C. pneumoniae Case only 51 80/– 51/– Blasi et al., 1996 [10]
Case only 12 67/– 50/– Juvonen et al., 1997 [65]
Case only 139
c 75/– ND Lindholt et al., 1999 [40]
Case only 22 54/– ND Halme et al., 1999 [41]
Case–control 81/56 96/88 ND Blanchard et al., 2000 [37]
Case only 102 61/– 32/– Porqueddu et al., 2002 [66]
Case–control 119/36 74/72 ND Nyberg et al., 2007 [67]
Case–control 68/68 47/37 0/0
d Falkensammer et al., 2007 [8]
Case only 211
c 76/– ND Karlsson et al., 2009 [68]
Case–control 50/110 82/77 ND Vikatmaa et al., 2010 [69]
Case–control 42/100 82/70 ND Karlsson et al., 2011 [38]
H. pylori Case only 51 92/– 0/– Blasi et al., 1996 [10]
B. burgdorferi sl Case–control 96/108 34/16 0/–
e Present study
aThe numbers indicate the percentage of positive samples in each study group
bThe presence of microorganism-specific DNA sequences in aortic wall tissue samples was assayed by PCR-based techniques
cStudy on AAA expansion
dNew sample set of 30 cases/15 controls. These samples were also tested for the presence of Borrelia DNA and all samples were negative for
Borrelia DNA
eAnalyzed in ten seropositive and 16 seronegative cases
ND not determined
786 Eur J Clin Microbiol Infect Dis (2012) 31:781–789from the same geographic region of Germany. No Borrelia-
specific DNA was detected in seropositive AAA specimens
using a sensitive PCR-based assay. These observations led us
to speculate that B. burgdorferi sl acts through autoimmunity
and molecular mimicry in AAAs and that B. burgdorferi sl is
one component in the complex disease process of AAAs.
Patients who have antibodies against B. burgdorferi sl and
develop AAAs might have genetic susceptibility to AAAs
and the microorganism acts as an environmental trigger in
the disease process.
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